Up­dat­ed: Re­silience to cut most staff, sus­pend op­er­a­tions at Mass­a­chu­setts man­u­fac­tur­ing plant

Na­tion­al Re­silience, a biotech man­u­fac­tur­ing start­up fund­ed with more than $2 bil­lion since its launch in Ju­ly 2020, has sent no­tices to em­ploy­ees that it will cut jobs at a Mass­a­chu­setts man­u­fac­tur­ing site that it bought just two years ago, cit­ing re­duced de­mand.

Mul­ti­ple peo­ple whose LinkedIn pro­files said they had been em­ploy­ees at the plant post­ed over the week­end say­ing they were told the site will shut down. In a fol­low-up in­ter­view, CEO Rahul Singhvi told End­points News that Re­silience is keep­ing the fa­cil­i­ty in a “state of readi­ness” as it seeks new cus­tomer[s]. The com­pa­ny has put $150 mil­lion to $200 mil­lion in­to the site since ac­quir­ing it.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN